Hereditary Non-Polyposis Colon Cancer and Microsatellite instability
|
|
- Rosaline Austin
- 6 years ago
- Views:
Transcription
1 Hereditary Non-Polyposis Colon Cancer and Microsatellite instability Byoung Kwon Kim M.D., M.S., IFCAP Department of Pathology and Medical Genetics Institute, Green Cross Reference Laboratory
2 Agenda Long history of HNPCC and mismatch repair system Microsatellite and it s instability Clinical implication of MSI Q&A
3 Agenda Long history of HNPCC and mismatch repair system Microsatellite and it s instability Clinical implication of MSI Q&A
4 Colorectal cancer Sporadic colorectal cancer (CRC) Hereditary (familial) CRC Lynch et al., 2004
5 Colorectal cancer carcinogenesis Normal gland Adenoma Carcinoma Vogelstein et al., 2004; Vilar et al., 2010
6 Colorectal cancer carcinogenesis Important concept of CRC carcinogenesis - Multistep genetic alteration in accordance with pathologic alteration - Oncogene / Tumor suppressor gene - Chromosomal (structural) instability Vogelstein et al., 2004; Vilar et al., 2010
7 Earlier records on Hereditary Non- Polyposis Colon Cancer (HNPCC) Cancer Family G was described by Aldred Warthin in 1895 and reported in Henry T. Lynch described 2 Midwestern kindred's as having a cancer family syndrome in 1966.
8
9 HNPCC vs. sporadic colorectal cancer Autosomal dominant trait (familial) Mean age of diagnosis; 41 years Proximal location of splenic flexure; 68% More than one; 7% Less metastatic tendency (good prognosis) Extra-colonic cancer risk; stomach, endometrium, biliary system, urinary system Lynch et al., 1966, Myrho et al., 1997
10 Questions Polygenic or monogenic? AD trait à probable monogenic nature What causes HNPCC? à mapping and cloning of the possible gene
11 Genetic mapping Linkage analysis using 345 microsatellite markers à narrow down to D2S*** (Peltomaki et al., 1993)
12 Genetic mapping Z max at D2S123 with no recombination (Peltomaki et al., 1993)
13 Genetic mapping Microsatellite syntany around D2S123 11cM 14cM 5cM D2S119 D2S5 D2S123 D2S136 D2S5; Previously known as located at 2p15~16 (Peltomaki et al., 1993)
14 Genetic mapping Aaltonen et al., (1993) studied different families from those studied by Peltomaki et al., (1993). Linkage analysis using microsatellite markers and formalin-fixed paraffin-embedded (FFPE) normal and tumor tissues.
15 Genetic mapping Aaltonen s mapping result Not consistent LOD score!!! à genetic heterogenity of HNPCC families involved in his study? (Aaltonen et al., 1993)
16 Genetic mapping Aaltonen s unexpected results Wide spread alteration in short repeat DNA sequences, (CA) n dinucleotide repeat fragments (Aaltonen et al., 1993)
17 Genetic mapping Aaltonen s unexpected results Normal chromosomal structure (No chromosomal instability) 13% of non-familial (sporadic) CRC showed identical alteration in microsatellite sequences with preference to proximal (right-sided) location (later reports; 10~15% of sporadic CRC) ~existence of a gene on chromosome 2 which is neither an oncogene nor a tumor suppressor gene, but rather a gene leading to genomic instability ~ (cf. chromosomal instability in sporadic CRC) (Aaltonen et al., 1993)
18 ? Perspective from microbial geneticist Proof reading ~10-10 REAL WORLD Proof reading? Proof reading Base selection Replicative polymerases complex ; family A (e.g. T7 Pol), family B (e.g. T4 Pol, Pol δ, Pol ϵ) and family C (e.g. E. coli Pol III). Proofreading-defective derivatives (designated A, B, C, and RT, for viral reverse transcriptase) Kunkel TA, 2004
19 Earlier records on mismatch repair system Cloning of the hexa mismatch-repair gene of Streptococcus pneumoniae and identification of the product. (Martin et al., 1986) Nucleotide sequence of the hexa gene for DNA mismatch repair in Streptococcus pneumoniae and homology of hexa to muts of Escherichia coli and Salmonella typhimurium. (Priebe, S.D. et al. 1988)
20 Perspective from microbial geneticist Prokaryote mismatch repair (MMR) system E. coli Mut HLS pathway (Mut H, MutL, MutS + UveD(helicase II)) acting on recombination intermediate with mis-paired bases (Wagner et al., 1976) E. coli also has a long patch (~2Kb) excision repair system (Modrich et al., 1989) Eukaryote mismatch repair (MMR) system S. cerevisiae has MMR system (Holliday et al., 1964) MutS homology, MSH was identified and characterized (MSH2 by Reeman et al., 1992, MSH3 by New et al., 1993, MSH4 by Ross-McDonald et al., 1993) MutL homology, MLH1 & PMS1 by Kramer et al., 1981 Mutant msh2, pms1 or mlh1 increased rates of expansion and contraction of dinucleotide repeats (Strand et al., 1993)
21 Bacterial MMR system During DNA replication Horvat M & Stabuc B, 2011
22 Bacterial MMR system During DNA replication Horvat M & Stabuc B, 2011
23 Bacterial MMR system During DNA replication Horvat M & Stabuc B, 2011
24 Perspective from microbial geneticist Certain types of human hereditary and sporadic cancer show similar alteration in short repeat DNA sequences like in microbes (Aaltonen et al., 1993, Ionove et al., 1993, Thibodeu et al., 1993) possibility of existence of human homologous protein of MMR system
25 Perspective from microbial geneticist bacterial muts vs. yeast msh2 protein
26 Perspective from microbial geneticist Degenerate PCR strategy using total RNA RT template ---TGPNM F(ATV)TH(FY)----- TGPNM à ß FATH(FY) ß FTTH(FY) ß FVTH(FY) (Fishel et al., 1993)
27 Cloning of HUMAN MSH bp ORF 909 amino acids; 41% homology with S. cerevisiae msh2 (Fishel et al., 1993)
28 Cloning of human MSH2 MutS MMR protein superfamily (Fishel et al., 1993)
29 Chromosome mapping Hybrid chromosome analysis using Chinese hamster cell line Chromosome 2!!!
30 Chromosome mapping Mouse chr 17 ßà Human chr 2 syntany Linkage analysis using (B6xM. spretus)f1 back cross Mapping!!! Chr2p22-21 (cf. 2p16~15 by Peltomaki et al., 1993)
31 Gene to disease causality Mutation analysis of hmsh2 with small HNPCC family (pph blood, screening with SSCP à direct sequencing) normal Top strand (forward) Bottom strand (backward) normal HNPCC HNPCC (Fishel et al., 1993)
32 Summary of genes and mapping of HNPCC subtypes phenotype location Gene/locus authors Type 1 2p21 MSH2 Fishel et al., 1993; Leach et al., 1994 Type 2 3p22.2 MLH1 Lindblom et al., 1993 Type 3 2q32.2 PMS1 Nicolaides et al., 1994 Type 4 7p22.1 PMS2 Nicolaides et al., 1994 Type 5 2p16.3 MSH6 Wijnen et al., 1999 Type 6 3p24.1 TGFBR2 Lu et al., 1998 Type 7 14q24.3 MLH3 Liu et al., 2003 Type 8 2p21 EPCAM Chan et al., 2006
33 Summary of genes and mapping of HNPCC subtypes phenotype location Gene/locus authors Type 1 2p21 MSH2 Fishel et al., 1993; Leach et al., 1994 Type 2 3p22.2 MLH1 Lindblom et al., 1993 Type 3 2q32.2 PMS1 Nicolaides et al., 1994 Type 4 7p22.1 PMS2 Nicolaides et al., 1994 Type 5 2p16.3 MSH6 Wijnen et al., 1999 Type 6 3p24.1 TGFBR2 Lu et al., 1998 Type 7 14q24.3 MLH3 Liu et al., 2003 Type 8 2p21 EPCAM Chan et al., 2006
34 Kariola R, 2004
35 Mismatch repair system E. coli system Yeast system Vilar E & Gruber SB, 2010 Kariola R, 2004
36 MMR defect and carcinogenesis -HNPCC- Germline mutation 1 st hit MMR gene Somatic mutation 2 nd hit Malfunction Dysfunction Alteration in expression level MMR defect Global genomic instability Increased mutation rate in satellite DNA (genes with microsatellite in coding region) Increased mutation rate in non-satellite DNA
37 MMR defect and carcinogenesis -sporadic colon cancer- Promoter hypermethylation MMR gene Alteration in expression level MMR defect Promoter hypermethylation Global genomic instability Increased mutation rate in satellite DNA (genes with microsatellite in coding region) Increased mutation rate in non-satellite DNA
38 Colorectal cancer carcinogenesis -dual pathway- ~85% Chromosomal instability (CIN) ~15% Microsatellite instability (MSI)
39 Agenda Long history of HNPCC and mismatch repair system Microsatellite and it s instability Clinical implication of MSI Q&A
40 Satellite DNA Equilibrium density gradient centrifugation concentration gradient using cesium chloride analysis of buoyant density of sheared DNA fragments Satellite peak was identified in Yeast-Moustacchi E & Williamson DH, 1966 Bacteria-Douthit HA & Halvorson HO, 1966 Mouse-Flamm et al., 1966 Human-Corneo et al., 1967
41 Repeated sequences in genome Category Tandem repeat Interspersed repeat Genomic island Repeat sequences Satellite DNA (VNTR-minisatellite, STR-microsatellite) transposon retrotransposon SINEs Alu, MIR DNA transposon Genomic island LINEs LTR LINE1, LINE2 MER4, HERV, retroposon MER1, MER2, mariners
42 Microsatellite Synonym ; Short tandem repeat (STR) Definition varies among researchers (arbitrary) Repeat unit; 1~6bp, 2~4bp, 2~6bp, 1~10bp Length; five times or more, eight times or more, five times to 5000 times
43 Microsatellite Schlotterer C & Harr B, 2001
44 Microsatellite General characteristics Comprise 3% of the human genome with more than one million loci Frequency; di->mono->tetra->tri- Single copy with length polymorphism Slightly higher mutation rate than other genomic area during replication Mostly located in intergenic and intronic area, a few cases in coding region (TGFbRII, IGFRII, Bax, E2F4, hmsh3, hmsh6 ) Application Forensic science/paternity test/linkage analysis (mapping)/population genetics (HNPCC screening)
45 Replication slippage If intact MMR restoration restoration Mismatch error is very rare but happens even in intact MMR system! Eg.) Meiosis (sperm); rare but happens! à polymorphism, disease
46 Replication slippage If defective MMR Higher rate of error during synthesis by Taq pol.(pcr reaction) à stutter bands of repeated DNA sequence Higher rate of error during cell division(mitosis) of cancer à MSI and global genomic instability
47 Definition of Microsatellite instability Definition of instability; aberrant peak in tumor, aberrant morphology in tumor, 5bp shift MSI is defined as a change of any length due to either insertion or deletion of repeating units, in a microsatellite within a tumor when compared to normal tissue. (Boland et al., in NCI workshop, 1998) stable unstable Oslo University Hospital,
48 Which microsatellites are used?
49
50 Microsatellite instability
51 Agenda Long history of HNPCC and mismatch repair system Microsatellite and it s instability Clinical implication of MSI Q&A
52 -Colorectal cancer (n=509) -MSI analysis in all cases -Genetic analysis of hmlh1 & hmsh2 in all cases (thus, considering genetic features first clinical features later)
53 Aaltonen et al., 1998
54 Aaltonen et al., 1998
55 Immunohistochemistry and/or MSI analysis 42 patients with colorectal carcinoma 11 met the Amsterdam criteria 31 were suspected HNPCC families. IHC + MSI analysis+ sequencing of MLH1, MSH2 using normal and tumor tissues Christensen et al., 2002
56 Immunohistochemistry and/or MSI analysis Christensen et al., 2002
57 Germline mutation in MLH1 or MSH2 N=13 Wild type in MLH1 or MSH2 N=18 Christensen et al., 2002
58 Germline mutation (MLH1 or MSH2) (n=13) 중에서 IHC 시행한환자 11 명, 이중에서 IHC 상에 MLH1 and/or MSH2 loss 있는경우 (n=8) Sensitivity ; 8/11 =72.7% Christensen et al., 2002
59 MLH1 or MSH2 유전자 WT 인환자 (n=18) 중에서 IHC 한환자 18 명, IHC 상 MLH1 and/or MSH2 loss 있는경우 3 명 (MLH1 만주로 loss) Specificity ; 15/18=83.3% Christensen et al., 2002
60 Germline mutation (MLH1 or MSH2) (n=13) 중에서 MSI 시행한환자 12 명, 이중 MSI-H 인경우 11 명 Sensitivity ; 11/12 =91.7% Christensen et al., 2002
61 MLH1 or MSH2 유전자 WT 인환자 (n=18) 중에서 MSI 시행한환자 13 명, MSI-H 인경우 4 Specificity ; 9/13=69.2% Christensen et al., 2002
62 Germline mutation (MLH1 or MSH2) (n=10) 중에서 MSI-H + IHC loss; 10 Sensitivity ; 10/10 =100% MLH1 or MSH2 유전자 WT 인환자 (n=13) 중에서 MSI-H + IHC loss; 5 Specificity ; 8/13=61.5% Christensen et al., 2002
63
64
65 MSI and prognosis In 1966, HNPCC show better survival than stage-matched sporadic CRC patients. Clinically HNPCC 10~15% of sporadic CRC show MSI and have similar pathologic features like HNPCC. Control ; sporadic CRC Any relationship between MSI and prognosis? à sporadic CRC with MSI vs. sporadic CRC without MSI
66 Population based series of 607 sporadic CRC Gryfe et al., 2000
67 Gryfe et al., 2000
68 Gryfe et al., 2000
69 Gryfe et al., 2000
70 Large series of sporadic CRC (n~1300) ; MSI vs. MSS Samowitz et al., 2001
71 MSI and prognosis 4 meta-analysis results Horvat M & Stabuc B, 2011
72 MSI and chemo-response Several cell-based studies, xenograft studies à discordant results, slightly favor 5-FU 570 patients with CRC previously enrolled in 5 phase III trials of adjuvant chemotherapy (5-FU) à MSI and response? Ribic et al., 2003
73 Vilar E & Gruber SB, 2010
74 Ribic et al., 2003
75 Ribic et al., 2003
76 Ribic et al., 2003
77 (MSI+chemo and MSS+chemo) No chemo HR = 1 (MSS/MSL+chemo) (MSI-H+chemo) Ribicet al., 2003
78 Clinical implication of MSI Screening method of HNPCC combined with IHC of MMR proteins Good prognostic marker in sporadic CRC No benefit for 5-FU based chemotherapy
79 녹십자의료재단 MSI 검사의차별점 종양부분병리전문의직접리뷰 à analytical sensitivity Multiplex PCR 결과 equivocal 시에는다시 simplex 로 PCR 시행 à failure rate
80 녹십자의료재단에서가능한 HNPCC 관련검사항목 IHC hmlh1 MSH2 MSH6 Genetic testing MSI testing; FFPE tissue B-RAF mutation testing; FFPE tissue K-RAS mutation testing; FFPE tissue hmlh1 germline genetic testing; blood hmsh2 germline genetic testing; blood
81 Agenda History of HNPCC and mismatch repair system Microsatellite and it s instability Clinical implication of MSI Q&A
Development of Carcinoma Pathways
The Construction of Genetic Pathway to Colorectal Cancer Moriah Wright, MD Clinical Fellow in Colorectal Surgery Creighton University School of Medicine Management of Colon and Diseases February 23, 2019
More informationTumorNext-Lynch. genetic testing for hereditary colorectal or uterine cancer
TumorNet-Lynch genetic testing for hereditary colorectal or uterine cancer What Are the Causes of Hereditary Colorectal Cancer? sporadic 70% familial 20% hereditary 10% Lynch syndrome, up to 4% Familial
More informationSerrated Polyps and a Classification of Colorectal Cancer
Serrated Polyps and a Classification of Colorectal Cancer Ian Chandler June 2011 Structure Serrated polyps and cancer Molecular biology The Jass classification The familiar but oversimplified Vogelsteingram
More informationGuidelines for the assessment of mismatch repair (MMR) status in Colorectal Cancer
Guidelines for the assessment of mismatch repair (MMR) status in Colorectal Cancer Start date: May 2015 Review date: April 2018 1 Background Mismatch repair (MMR) deficiency is seen in approximately 15%
More informationLynch Syndrome Screening for Endometrial Cancer: Basic Concepts 1/16/2017
1 Hi, my name is Sarah Kerr. I m a pathologist at Mayo Clinic, where I participate in our high volume Lynch syndrome tumor testing practice. Today I hope to cover some of the basics needed to understand
More informationCase Presentation Diana Lim, MBBS, FRCPA, FRCPath Senior Consultant Department of Pathology, National University Health System, Singapore Assistant Pr
Case Presentation Diana Lim, MBBS, FRCPA, FRCPath Senior Consultant Department of Pathology, National University Health System, Singapore Assistant Professor Yong Loo Lin School of Medicine, National University
More informationAnatomic Molecular Pathology: An Emerging Field
Anatomic Molecular Pathology: An Emerging Field Antonia R. Sepulveda M.D., Ph.D. University of Pennsylvania asepu@mail.med.upenn.edu 2008 ASIP Annual Meeting Anatomic pathology (U.S.) is a medical specialty
More informationColon Cancer and Hereditary Cancer Syndromes
Colon Cancer and Hereditary Cancer Syndromes Gisela Keller Institute of Pathology Technische Universität München gisela.keller@lrz.tum.de Colon Cancer and Hereditary Cancer Syndromes epidemiology models
More informationPolicy Specific Section: Medical Necessity and Investigational / Experimental. October 14, 1998 March 28, 2014
Medical Policy Genetic Testing for Colorectal Cancer Type: Medical Necessity and Investigational / Experimental Policy Specific Section: Laboratory/Pathology Original Policy Date: Effective Date: October
More informationFamilial and Hereditary Colon Cancer
Familial and Hereditary Colon Cancer Aasma Shaukat, MD, MPH, FACG, FASGE, FACP GI Section Chief, Minneapolis VAMC Associate Professor, Division of Gastroenterology, Department of Medicine, University of
More informationCélia DeLozier-Blanchet
The Genetics Consultation in OB-GYN : Hereditary cancers Célia DeLozier-Blanchet Division of Medical Genetics, Geneva University Hospital It is probable that all cancers are genetic! genetic vs. hereditary
More informationCase Study. Overview. Deleterious MLH1 mutation detected on sequencing 10/16/2014
The Role of Next Generation Sequencing for Hereditary Cancer Syndromes: A Focus on Endometrial Cancer Laura J. Tafe, MD Assistant Professor of Pathology Assistant Director, Molecular Pathology Dartmouth-Hitchcock
More informationColorectal cancer Chapelle, J Clin Oncol, 2010
Colorectal cancer Chapelle, J Clin Oncol, 2010 Early-Stage Colorectal cancer: Microsatellite instability, multigene assay & emerging molecular strategy Asit Paul, MD, PhD 11/24/15 Mr. X: A 50 yo asymptomatic
More informationGENETICS OF COLORECTAL CANCER: HEREDITARY ASPECTS By. Magnitude of the Problem. Magnitude of the Problem. Cardinal Features of Lynch Syndrome
GENETICS OF COLORECTAL CANCER: HEREDITARY ASPECTS By HENRY T. LYNCH, M.D. 1 Could this be hereditary Colon Cancer 4 Creighton University School of Medicine Omaha, Nebraska Magnitude of the Problem Annual
More informationCANCER. Inherited Cancer Syndromes. Affects 25% of US population. Kills 19% of US population (2nd largest killer after heart disease)
CANCER Affects 25% of US population Kills 19% of US population (2nd largest killer after heart disease) NOT one disease but 200-300 different defects Etiologic Factors In Cancer: Relative contributions
More informationMultistep nature of cancer development. Cancer genes
Multistep nature of cancer development Phenotypic progression loss of control over cell growth/death (neoplasm) invasiveness (carcinoma) distal spread (metastatic tumor) Genetic progression multiple genetic
More informationCOLORECTAL PATHWAY GROUP, MANCHESTER CANCER. Guidelines for the assessment of mismatch. Colorectal Cancer
COLORECTAL PATHWAY GROUP, MANCHESTER CANCER Guidelines for the assessment of mismatch repair (MMR) status in Colorectal Cancer January 2015 1 Background Mismatch repair (MMR) deficiency is seen in approximately
More informationCOLORECTAL PATHWAY GROUP, MANCHESTER CANCER. Guidelines for the assessment of mismatch. Colorectal Cancer
COLORECTAL PATHWAY GROUP, MANCHESTER CANCER Guidelines for the assessment of mismatch repair (MMR) status in Colorectal Cancer March 2017 1 Background Mismatch repair (MMR) deficiency is seen in approximately
More informationThe Whys OAP Annual Meeting CCO Symposium September 20. Immunohistochemical Assessment Dr. Terence Colgan Mount Sinai Hospital, Toronto
Immunohistochemical Assessment of Mismatch Repair Proteins in Endometrial Cancer: The Whys and How Terence J. Colgan, MD Head of Gynaecological Pathology, Mount Sinai Hospital, University of Toronto, Toronto.
More informationImmunotherapy in Colorectal cancer
Immunotherapy in Colorectal cancer Ahmed Zakari, MD Associate Professor University of Central Florida, College of Medicine Medical Director, Gastro Intestinal Cancer Program Florida Hospital Cancer Institute
More informationFamilial and Hereditary Colon Cancer
Familial and Hereditary Colon Cancer Aasma Shaukat, MD, MPH, FACG, FASGE, FACP GI Section Chief, Minneapolis VAMC Associate Professor, Division of Gastroenterology, Department of Medicine, University of
More informationMRC-Holland MLPA. Description version 29;
SALSA MLPA KIT P003-B1 MLH1/MSH2 Lot 1209, 0109. As compared to the previous lots 0307 and 1006, one MLH1 probe (exon 19) and four MSH2 probes have been replaced. In addition, one extra MSH2 exon 1 probe,
More informationColonic polyps and colon cancer. Andrew Macpherson Director of Gastroentology University of Bern
Colonic polyps and colon cancer Andrew Macpherson Director of Gastroentology University of Bern Improtance of the problem of colon cancers - Epidemiology Lifetime risk 5% Incidence/10 5 /annum (US Detroit
More informationYes when meets criteria below. Dean Health Plan covers when Medicare also covers the benefit.
Genetic Testing for Lynch Syndrome MP9487 Covered Service: Prior Authorization Required: Additional Information: Yes when meets criteria below Yes-as shown below Pre and post test genetic counseling is
More informationA Review from the Genetic Counselor s Perspective
: A Review from the Genetic Counselor s Perspective Erin Sutcliffe, MS, CGC Certified Genetic Counselor Cancer Risk Evaluation Program INTRODUCTION Errors in base pair matching that occur during DNA replication,
More informationMolecular biology of colorectal cancer
Molecular biology of colorectal cancer Phil Quirke Yorkshire Cancer Research Centenary Professor of Pathology University of Leeds, UK Rapid pace of molecular change Sequencing changes 2012 1,000 genomes
More informationB Base excision repair, in MUTYH-associated polyposis and colorectal cancer, BRAF testing, for hereditary colorectal cancer, 696
Index Note: Page numbers of article titles are in boldface type. A Adenomatous polyposis, familial. See Familial adenomatous polyposis. Anal anastomosis, ileal-pouch, proctocolectomy with, in FAP, 591
More informationContent. Diagnostic approach and clinical management of Lynch Syndrome: guidelines. Terminology. Identification of Lynch Syndrome
of Lynch Syndrome: guidelines 17/03/2009 Content Terminology Lynch Syndrome Presumed Lynch Syndrome Familial Colorectal Cancer Identification of Lynch Syndrome Amsterdam II criteria Revised Bethesda Guidelines
More informationUniversal Screening for Lynch Syndrome
Universal Screening for Lynch Syndrome St. Vincent/Ameripath protocol proposal Lynch syndrome (HNPCC) 1/35 individuals with colorectal cancer has Lynch syndrome Over half individuals are >50 at time of
More informationMarcatori biomolecolari dei carcinomi del colon-retto sporadici ed ereditari
Marcatori biomolecolari dei carcinomi del colon-retto sporadici ed ereditari Milo Frattini XII Congresso AIFEG Villa Cagnola - Gazzada Schianno (VA) 16/17.10.2014 APC β-catenina APC Met (p16) Models of
More informationMicrosatellite instability and other molecular markers: how useful are they?
Microsatellite instability and other molecular markers: how useful are they? Pr Frédéric Bibeau, MD, PhD Head, Pathology department CHU de Caen, Normandy University, France ESMO preceptorship, Barcelona,
More informationBRAF Testing In The Elderly: Same As in Younger Patients?
EGFR, K-RAS, K BRAF Testing In The Elderly: Same As in Younger Patients? Nadine Jackson McCleary MD MPH Gastrointestinal Oncology Dana-Farber/Harvard Cancer Care Boston, MA, USA Outline Colorectal cancer
More informationManagement of higher risk of colorectal cancer. Huw Thomas
Management of higher risk of colorectal cancer Huw Thomas Colorectal Cancer 41,000 new cases pa in UK 16,000 deaths pa 60% 5 year survival Adenoma-carcinoma sequence (Morson) Survival vs stage (Dukes)
More informationClinicopathologic Characteristics of Left-Sided Colon Cancers with High Microsatellite Instability
The Korean Journal of Pathology 29; 43: 428-34 DOI: 1.4132/KoreanJPathol.29.43.5.428 Clinicopathologic Characteristics of Left-Sided Colon Cancers with High Microsatellite Instability Sang Kyum Kim Junjeong
More informationGenetic Aspects of Inherited colorectal cancer (CRC)
Genetic Aspects of Inherited colorectal cancer (CRC) New data New insights DNA repair Cancer Hub 3/2014 2004 Service for genetics of GI Cancer Oncology Tamar Peretz A. Hubert L. Kadouri N. Halpern M. Plesser
More informationMolecular markers in colorectal cancer. Wolfram Jochum
Molecular markers in colorectal cancer Wolfram Jochum Biomarkers in cancer Patient characteristics Tumor tissue Normal cells Serum Body fluids Predisposition Diagnostic marker Specific diagnosis Prognostic
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/22278 holds various files of this Leiden University dissertation. Author: Cunha Carvalho de Miranda, Noel Filipe da Title: Mismatch repair and MUTYH deficient
More informationGenetic Modifiers of Chemotherapy for Colorectal Cancer
Genetic Modifiers of Chemotherapy for Colorectal Cancer September 27, 2011 John M. Carethers, M.D. Professor of Internal Medicine University of Michigan 1,233,700 cases/year Worldwide ~146,000 cases/year
More informationKeywords: microsatellite instability; multiple primary cancer; hereditary non-polyposis colorectal cancer
790 Gut 2000;46:790 794 First Department of Internal Medicine, Sapporo Medical University, Sapporo, K Yamashita Y Arimura S Kurokawa F Itoh T Endo K Imai First Department of Surgery, Sapporo Medical University,
More informationColorectal carcinoma (CRC) was traditionally thought of
Testing for Defective DNA Mismatch Repair in Colorectal Carcinoma A Practical Guide Lawrence J. Burgart, MD Context. Significant bench and clinical data have been generated during the last decade regarding
More informationIntroduction retroposon
17.1 - Introduction A retrovirus is an RNA virus able to convert its sequence into DNA by reverse transcription A retroposon (retrotransposon) is a transposon that mobilizes via an RNA form; the DNA element
More informationMeasure Description. Denominator Statement
CMS ID/CMS QCDR ID: CAP 18 Title: Mismatch Repair (MMR) or Microsatellite Instability (MSI) Biomarker Testing to Inform Clinical Management and Treatment Decisions in Patients with Primary or Metastatic
More informationLYNCH SYNDROME: IN YOUR FACE BUT LOST IN SPACE (MOUNTAIN)!
LYNCH SYNDROME: IN YOUR FACE BUT LOST IN SPACE (MOUNTAIN)! Kathryn Singh, MPH, MS, LCGC Associate Clinical Professor Assistant Director, Graduate Program in Genetic Counseling Division of Genetic and Genomic
More informationIntroduction. Why Do MSI/MMR Analysis?
Clinical Significance Of MSI, KRAS, & EGFR Pathway In Colorectal Carcinoma UCSF & Stanford Current Issues In Anatomic Pathology Introduction Microsatellite instability and mismatch repair protein deficiency
More informationAccumulated Clonal Genetic Alterations in Familial and Sporadic Colorectal Carcinomas with Widespread Instability in Microsatellite Sequences
American Journal of Pathology, Vol. 153, No. 4, October 1998 Copyright American Society for Investigative Pathology Accumulated Clonal Genetic Alterations in Familial and Sporadic Colorectal Carcinomas
More informationGenetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes
Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes Policy Number: Original Effective Date: MM.02.007 09/01/2011 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration
More informationMolecular mechanisms of human carcinogenesis
Cancer: Cell Structures, Carcinogens and Genomic Instability Edited by Leon P. Bignold 2006 Birkhäuser Verlag/Switzerland 321 Molecular mechanisms of human carcinogenesis William B. Coleman 1 and Gregory
More informationGenetic Testing for Familial Gastrointestinal Cancer Syndromes. C. Richard Boland, MD La Jolla, CA January 21, 2017
Genetic Testing for Familial Gastrointestinal Cancer Syndromes C. Richard Boland, MD La Jolla, CA January 21, 2017 Disclosure Information C. Richard Boland, MD I have no financial relationships to disclose.
More informationMolecular Diagnosis for Colorectal Cancer Patients
Molecular Diagnosis for Colorectal Cancer Patients Antonia R. Sepulveda MD, PhD, FCAP October, 20, 2010 www.cap.org Welcome to the PHC Webinar Series This talk on The Molecular Diagnosis for Colorectal
More informationResource impact report: Molecular testing strategies for Lynch syndrome in people with colorectal cancer (DG27)
Putting NICE guidance into practice Resource impact report: Molecular testing strategies for Lynch syndrome in people with colorectal cancer (DG27) Published: February 2017 Summary Molecular testing strategies
More informationASSESSMENT OF MLH1 PROMOTER METHYLATION IN ENDOMETRIAL CANCER USING PYROSEQUENCING TECHNOLOGY OBJECTIVES
ASSESSMENT OF MLH1 PROMOTER METHYLATION IN ENDOMETRIAL CANCER USING PYROSEQUENCING TECHNOLOGY Authors: Duilio Della Libera, Alessandra D Urso, Federica Modesti, Georgeta Florea, Marta Gobbato Hospital:
More informationHST.161 Molecular Biology and Genetics in Modern Medicine Fall 2007
MIT OpenCourseWare http://ocw.mit.edu HST.161 Molecular Biology and Genetics in Modern Medicine Fall 2007 For information about citing these materials or our Terms of Use, visit: http://ocw.mit.edu/terms.
More informationGenetic Testing for Lynch Syndrome
Genetic Testing for Lynch Syndrome MP9487 Covered Service: Prior Authorization Required: Additional Information: Yes when meets criteria below Yes-as shown below Pre and post-test genetic counseling is
More informationNew Strategy For Treatment Of Hereditary Colorectal Cancer By Shozo Baba
New Strategy For Treatment Of Hereditary Colorectal Cancer By Shozo Baba If you are looking for a book by Shozo Baba New Strategy for Treatment of Hereditary Colorectal Cancer in pdf form, then you have
More informationIntroduction. Chapter 1
Introduction Chapter 1 1.1 Colorectal cancer Transformation from normal cell to cancer cell is thought to be a multi-step process involving the accumulation of genetic alterations in oncogenes, tumor
More informationHereditary Non Polyposis Colorectal Cancer(HNPCC) From clinic to genetics
From clinic to genetics Question 1) Clinical pattern of inheritance of the HNPCC-Syndrome? Question 1) Clinical pattern of inheritance of the HNPCC-Syndrome? Autosomal dominant Question 2) Incidence of
More informationMr Chris Wakeman. General Surgeon University of Otago, Christchurch. 12:15-12:40 Management of Colorectal Cancer
Mr Chris Wakeman General Surgeon University of Otago, Christchurch 12:15-12:40 Management of Colorectal Cancer Bowel cancer Chris Wakeman Colorectal Surgeon Christchurch Sam Simon (Simpsons) Elizabeth
More informationPrior Authorization. Additional Information:
Genetic Testing for Lynch Syndrome MP9487 Covered Service: Prior Authorization Required: Additional Information: Yes when meets criteria below Yes-as shown below Pre and post test genetic counseling is
More informationHigh risk stage II colon cancer
High risk stage II colon cancer Joel Gingerich, MD, FRCPC Assistant Professor Medical Oncologist University of Manitoba CancerCare Manitoba Disclaimer No conflict of interests 16 October 2010 Overview
More informationThe molecular genetics of colorectal cancer
1 Department of Gastroenterology, North Middlesex University Hospital, London, UK 2 Institute of Molecular Genetics, Cardiff University 3 Department of Gastroenterology, Queen s Hospital Romford, London,
More informationReview Article Relationship between DNA Mismatch Repair Deficiency and Endometrial Cancer
SAGE-Hindawi Access to Research Molecular Biology International Volume 2011, Article ID 256063, 6 pages doi:10.4061/2011/256063 Review Article Relationship between DNA Mismatch Repair Deficiency and Kenta
More informationInherited colon cancer and other inherited cancer predispositions. Dr Anne De Leener Centre de Génétique Humaine
14.20-15.00 Inherited colon cancer and other inherited cancer predispositions Dr Anne De Leener Centre de Génétique Humaine INHERITED COLORECTAL CANCER (CRC) Colorectal cancer 5% 1% 10% 84% Sporadic Familial
More informationCOLON CANCER GENETICS (FOR SURGEONS) Mark W. Arnold MD Chief, Division of Colon and Rectal Surgery Professor of Surgery The Ohio State University
COLON CANCER GENETICS (FOR SURGEONS) Mark W. Arnold MD Chief, Division of Colon and Rectal Surgery Professor of Surgery The Ohio State University 1. I am a surgeon; of course I have nothing to disclose.
More informationCAP Laboratory Improvement Programs. Summary of Microsatellite Instability Test Results From Laboratories Participating in Proficiency Surveys
CAP Laboratory Improvement Programs Summary of Microsatellite Instability Test Results From Laboratories Participating in Proficiency Surveys Proficiency Survey Results From 2005 to 2012 Theresa A. Boyle,
More informationMolecular subtyping: how useful is it?
Molecular subtyping: how useful is it? Daniela E. Aust, Institute for Pathology, University Hospital Dresden, Germany Center for Molecular Tumor Diagnostics at the NCT-Partner Site Dresden CMTD Disclosure
More informationColorectal Carcinoma Reporting in 2009
Colorectal Carcinoma Reporting in 2009 Overview Colorectal carcinoma- new and confusing AJCC TNM issues Wendy L. Frankel, M.D. Vice-Chair and Director of AP Department of Pathology The Ohio State University
More informationCOLON CANCER & GENETICS VERMONT COLORECTAL CANCER SUMMIT NOVEMBER 15, 2014
COLON CANCER & GENETICS VERMONT COLORECTAL CANCER SUMMIT NOVEMBER 15, 2014 WENDY MCKINNON, MS, CGC CERTIFIED GENETIC COUNSELOR FAMILIAL CANCER PROGRAM UNIVERSIT Y OF VERMONT MEDICAL CENTER 1 CHARACTERISTICS
More informationRisk of Colorectal Cancer (CRC) Hereditary Syndromes in GI Cancer GENETIC MALPRACTICE
Identifying the Patient at Risk for an Inherited Syndrome Sapna Syngal, MD, MPH, FACG Director, Gastroenterology Director, Familial GI Program Dana-Farber/Brigham and Women s Cancer Center Associate Professor
More informationMale Factor Infertility and Health. Karen Baker, MD Associate Professor Duke University, Division of Urology
Male Factor Infertility and Health Karen Baker, MD Associate Professor Duke University, Division of Urology Fertility and Cancer Heart disease Metabolic syndrome Diabetes Early death Goals: Review literature
More informationMicrosatellite Instability and Mismatch Repair Protein (hmlh1, hmsh2) Expression in Intrahepatic Cholangiocarcinoma
The Korean Journal of Pathology 2005; 39: 9-14 Microsatellite Instability and Mismatch Repair Protein (hmlh1, hmsh2) Expression in Intrahepatic Cholangiocarcinoma Yun Kyung Kang Woo Ho Kim 1 Department
More informationCourse Title Form Hours subject
Course Title Form Hours subject Types, and structure of chromosomes L 1 Histology Karyotyping and staining of human chromosomes L 2 Histology Chromosomal anomalies L 2 Histology Sex chromosomes L 1 Histology
More informationColorectal adenocarcinoma leading cancer in developed countries In US, annual deaths due to colorectal adenocarcinoma 57,000.
Colonic Neoplasia Remotti Colorectal adenocarcinoma leading cancer in developed countries In US, annual incidence of colorectal adenocarcinoma 150,000. In US, annual deaths due to colorectal adenocarcinoma
More informationINMUNOTERAPIA EN CANCER COLORRECTAL METASTASICO. CCRm MSI-H NUEVO ESTANDAR EN PRIMERA LINEA Y/O PRETRATADOS?
INMUNOTERAPIA EN CANCER COLORRECTAL METASTASICO CCRm MSI-H NUEVO ESTANDAR EN PRIMERA LINEA Y/O PRETRATADOS? V. Alonso Servicio de Oncologia Medica H. U. Miguel Servet Zaragoza MSI-H mcrc Clinical and Pathological
More informationSection 9. Junaid Malek, M.D.
Section 9 Junaid Malek, M.D. Mutation Objective: Understand how mutations can arise, and how beneficial ones can alter populations Mutation= a randomly produced, heritable change in the nucleotide sequence
More informationFROM EDUCATION TO TUMOUR CHARACTERISTICS IN COLORECTAL CANCER: AN ANALYSIS OF THE PATHWAYS
FROM EDUCATION TO TUMOUR CHARACTERISTICS IN COLORECTAL CANCER: AN ANALYSIS OF THE PATHWAYS By Parisa Airia A thesis submitted in conformity with the requirements for the degree of PhD Dalla Lana School
More informationHyperplastic polyps in hereditary nonpolyposis colorectal cancer
4 Hyperplastic polyps in hereditary nonpolyposis colorectal cancer F E M Rijcken 1, T van der Sluis 2, H Hollema 2, J H Kleibeuker 1 Department of Gastroenterology 1 and Pathology 2, University Medical
More informationSALSA MS-MLPA KIT ME011-A1 Mismatch Repair genes (MMR) Lot 0609, 0408, 0807, 0407
SALSA MS-MLPA KIT ME011-A1 Mismatch Repair genes (MMR) Lot 0609, 0408, 0807, 0407 The Mismatch Repair (MMR) system is critical for the maintenance of genomic stability. MMR increases the fidelity of DNA
More informationColorectal Cancer - Working in Partnership. David Baty Genetics, Ninewells Hospital
Colorectal Cancer - Working in Partnership David Baty Genetics, Ninewells Hospital Genetics and Pathology National initiatives Colorectal cancer Inherited CRC Sporadic CRC The Liquid Biopsy The future?
More informationVENTANA MMR IHC Panel Interpretation Guide for Staining of Colorectal Tissue
VENTANA MMR IHC Panel Interpretation Guide for Staining of Colorectal Tissue VENTANA anti-mlh1 (M1) Mouse Monoclonal Primary Antibody VENTANA anti-pms2 (A16-4) Mouse Monoclonal Primary Antibody VENTANA
More informationThe Next Generation of Hereditary Cancer Testing
The Next Generation of Hereditary Cancer Testing Why Genetic Testing? Cancers can appear to run in families. Often this is due to shared environmental or lifestyle patterns, such as tobacco use. However,
More informationCurrent and future applications of Molecular Pathology. Kathy Walsh Clinical Scientist NHS Lothian
Current and future applications of Molecular Pathology Kathy Walsh Clinical Scientist NHS Lothian Molecular Pathology in Solid tumours Cancer type Genes tested Purpose Associated treatments Non small cell
More informationColon Cancer Update Christie J. Hilton, DO
POMA Winter Conference Christie Hilton DO Medical Oncology January 2018 None Colon Cancer Numbers Screening (brief update) Practice changing updates in colon cancer MSI Testing Immunotherapy in Colon Cancer
More informationSubject: Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes
05-82000-31 Original Effective Date: 10/15/01 Reviewed: 10/25/18 Revised: 11/15/18 Subject: Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes THIS MEDICAL COVERAGE GUIDELINE
More informationComparison of the Mismatch Repair System between Primary and Metastatic Colorectal Cancers Using Immunohistochemistry
Journal of Pathology and Translational Medicine 2017; 51: 129-136 ORIGINAL ARTICLE Comparison of the Mismatch Repair System between Primary and Metastatic Colorectal Cancers Using Immunohistochemistry
More informationGenetic testing all you need to know
Genetic testing all you need to know Sue Clark Consultant Colorectal Surgeon, St Mark s Hospital, London, UK. Colorectal cancer Familial 33% Polyposis syndromes
More informationOvarian cancer: 2012 Update Srini Prasad MD Univ Texas MD Anderson Cancer Center
Ovarian cancer: 2012 Update Srini Prasad MD Univ Texas MD Anderson Cancer Center Ovarian cancer is not a single disease Ovarian Epithelial Tumors: Histological Spectrum* Type Frequency Histology High-Grade
More informationAllinaHealthSystems 1
Overview Biology and Introduction to the Genetics of Cancer Denise Jones, MS, CGC Certified Genetic Counselor Virginia Piper Cancer Service Line I. Our understanding of cancer the historical perspective
More informationBiology of Cancer Writing Assignment
1 Biology of Cancer Writing Assignment Based on the information below, you will write a research proposal 3- pages in length (double-spaced, not including references). Draw upon information that you have
More informationClonal evolution of human cancers
Clonal evolution of human cancers -Pathology-based microdissection and genetic analysis precisely demonstrates molecular evolution of neoplastic clones- Hiroaki Fujii, MD Ageo Medical Laboratories, Yashio
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,350 108,000 1.7 M Open access books available International authors and editors Downloads Our
More informationNational Medical Policy
National Medical Policy Subject: Policy Number: Genetic Testing for Hereditary Nonpolyposis Colorectal Cancer (HNPCC) (Lynch Syndrome) NMP137 Effective Date*: April 2004 Updated: March 2017 This National
More informationColorectal Neoplasia. Dr. Smita Devani MBChB, MRCP. Consultant Physician and Gastroenterologist Aga Khan University Hospital, Nairobi
Colorectal Neoplasia Dr. Smita Devani MBChB, MRCP Consultant Physician and Gastroenterologist Aga Khan University Hospital, Nairobi Case History BT, 69yr male Caucasian History of rectal bleeding No change
More informationThe College of American Pathologists (CAP) offers these
CAP Laboratory Improvement Programs Template for Reporting Results of Biomarker Testing of Specimens From Patients With Carcinoma of the Endometrium Teri A. Longacre, MD; Russell Broaddus, MD, PhD; Linus
More informationHisto-prognostic factors what histopathology has to offer for clinical decision making
Histo-prognostic factors what histopathology has to offer for clinical decision making Daniela E. Aust Institute for Pathology, University Hospital Dresden, Germany Center for Molecular Tumor Diagnostics
More informationGenetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes Section 2.0 Medicine Subsection 2.04 Pathology/Laboratory
2.04.08 Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes Section 2.0 Medicine Subsection 2.04 Pathology/Laboratory Effective Date January 30, 2015 Original Policy Date October
More informationPrecision Genetic Testing in Cancer Treatment and Prognosis
Precision Genetic Testing in Cancer Treatment and Prognosis Deborah Cragun, PhD, MS, CGC Genetic Counseling Graduate Program Director University of South Florida Case #1 Diana is a 47 year old cancer patient
More informationDall istologia alla caratterizzazione biomolecolare
Il carcinoma ovarico: approccio multidisciplinare e prospettive terapeutiche Dall istologia alla caratterizzazione biomolecolare Anna Pesci Ospedale SC Don Calabria, Negrar anna.pesci@sacrocuore.it Ovarian
More informationIntroduction to Genetics
Introduction to Genetics Table of contents Chromosome DNA Protein synthesis Mutation Genetic disorder Relationship between genes and cancer Genetic testing Technical concern 2 All living organisms consist
More informationWhat Pathology can tell us in the approach of localized colorectal cancer
What Pathology can tell us in the approach of localized colorectal cancer A/Prof Tony Lim Kiat Hon Department of Anatomical Pathology Singapore General Hospital ESMO 2017 Singapore Nov 1 2 Do we still
More informationCurrent Status of Biomarkers (including DNA Tumor Markers and Immunohistochemistry in the Laboratory Diagnosis of Tumors)
Current Status of Biomarkers (including DNA Tumor Markers and Immunohistochemistry in the Laboratory Diagnosis of Tumors) Kael Mikesell, DO McKay-Dee Hospital May 14, 2015 Outline Update to DNA Testing
More information